Citation Impact
Citing Papers
All‐In‐One Dendrimer‐Based Lipid Nanoparticles Enable Precise HDR‐Mediated Gene Editing In Vivo
2021
Ferroptosis: past, present and future
2020 Standout
Macrophages and cancer stem cells: a malevolent alliance
2021
Engineering precision nanoparticles for drug delivery
2020 Standout
Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications
2017
From NASH to HCC: current concepts and future challenges
2019
The critical roles of somatic mutations and environmental tumor-promoting agents in cancer risk
2020
Ferroptosis: Death by Lipid Peroxidation
2015 Standout
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation
2019
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
2020
Advances in molecular classification and precision oncology in hepatocellular carcinoma
2020
Lipid nanoparticles for mRNA delivery
2021 Standout
Nonalcoholic Fatty Liver Disease in Latinos
2015
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Burden of liver diseases in the world
2018 Standout
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
2021 StandoutNobel
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma
2017
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
2014
Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm
2015
Nonalcoholic fatty liver disease in Asia: emerging perspectives
2016
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells
2014
Rational HCC screening approaches for patients with NAFLD
2021
Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma
2016
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
2016
Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis
2015
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis
2015
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
2017
Gut microbiome and health: mechanistic insights
2022 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Nonobese Fatty Liver Disease
2016
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33
2020
Should AFP (or Any Biomarkers) Be Used for HCC Surveillance?
2017
Non-alcoholic fatty liver disease
2021 Standout
Crohn's disease
2016 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
2020
Pathogenic Mechanisms of Somatic Mutation and Genome Mosaicism in Aging
2020
Global burden of liver disease: 2023 update
2023 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
2014
Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease
2016
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
2015
Ferroptosis: process and function
2016 Standout
Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond
2020
Ulcerative colitis
2020 Standout
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
2018
Genetics and epigenetics of NAFLD and NASH: Clinical impact
2017
Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing
2020
The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View
2017
International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma
2021
Epidemiology and surveillance for hepatocellular carcinoma: New trends
2020
Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma
2018
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
2020
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma
2020
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
The histopathological approach to inflammatory bowel disease: a practice guide
2014
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
2015
Hepatocellular carcinoma
2022 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
2015
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
2023 StandoutNobel
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Surveillance for Hepatocellular Carcinoma in Patients with NASH
2016
Gut Epithelial Metabolism as a Key Driver of Intestinal Dysbiosis Associated with Noncommunicable Diseases
2020
Targeted and Equally Distributed Delivery of mRNA to Organs with Pentaerythritol-Based One-Component Ionizable Amphiphilic Janus Dendrimers
2023 StandoutNobel
Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis
2016
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
2017
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
2015
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells
2017
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment
2017
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Lipid‐Modified Aminoglycosides for mRNA Delivery to the Liver
2020
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis
2020
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
2017
Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines
2013
Nonalcoholic Fatty Liver Disease
2015 Standout
An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis
2016
Dendrimer‐Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I
2018
Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells
2005
Works of Purva Gopal being referenced
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase
2017
Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients
2018
Factors That Affect Accuracy of α-Fetoprotein Test in Detection of Hepatocellular Carcinoma in Patients With Cirrhosis
2013
The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
2014
The Polyploid State Plays a Tumor-Suppressive Role in the Liver
2018
Accuracy of Ultrasound and Noninvasive Markers of Fibrosis to Identify Patients with Cirrhosis
2015
The Clinical Significance of Focally Enhanced Gastritis in Children
2012
Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration
2017
The Changing Landscape of Hepatocellular Carcinoma
2014
Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis
2020
Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease
2019
Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines
2002
Editing of the gut microbiota reduces carcinogenesis in mouse models of colitis-associated colorectal cancer
2019
Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States
2013